Where can I find more information about this study?
To learn more, you can find more detailed information on these websites:
• https://clinicaltrials.gov/ct2/show/NCT04590586?term=NCT04590586&draw=2&rank=1
• https://www.amgentrials.com
• https://clinicaltrials.takeda.com/.
Full study title: Industry Alliance Platform Trial to Assess the Efficacy and Safety of Multiple
Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
National Clinical Trial (NCT) identification number: NCT04590586
EudraCT number: 2020-002594-10
If there are more clinical studies with the investigational medications, you can find them on
the websites listed above by searching for: SARS-CoV-2, COVID-19, apremilast, lanadelumab-IV,
zilucoplan, Otezla®, or RA101495.
If you have any questions, please use the following contact details:
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 USA
Phone (United States): +1 805-447-1000
Queries specific to zilucoplan should be directed to www.ucb.com/UCBCares for country-
specific contact information.
Thank you to everyone who took part in this study. Participants in clinical studies
belong to a large community of people who take part in clinical research all around the
world. They help researchers answer important health questions and find new medical
treatments for patients.
Plain Language Summary of Results, 07 Apr 2022 [V01 Global(en)]
11